Rasburicase biosimilar (Virchow Group)

拉布立酶生物类似药（Virchow Group）

Report date: 2022/04/08 14:35:59

Base Information

Drug NameRasburicase biosimilar (Virchow Group)

Drug Alias NameRasburicasa (Virchow Group)尿酸水解酶生物仿制药（Virchow Group）拉布立酶生物仿制药（Virchow Group）Rasburicase (Virchow Group)Rasburicasum (Virchow Group) +[6]

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionUrate oxidases replacements

TargetsUrate oxidase

Therapy Area/IndicationsHyperuricemia

Global Approved IndicationsHyperuricemia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2012/08/28

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesVirchow Group

China Registration ClassN/A

Develop Information

Active CompaniesVirchow Group

Inactive CompaniesN/A

Active IndicationsHyperuricemia

Inactive IndicationsN/A

Other Information

ATC CodeV03AF07